PET/CT sample dictation
History: The patient is  year-old  with . Evaluate for [initial staging/restaging/recurrence/response to treatment].
Procedure: Following at least four-hour fasting, the patient's blood glucose was  mg/dL. One hour following the injection of 13 mCi of F-18-FDG, low dose CT images were obtained from the orbital meatal line through the pelvis. Then, PET images were obtained through the same region. Attenuation corrected images were constructed using the CT scan. Fused images of PET and CT were reviewed. The standard uptake values (SUV) reported below are maximum values within a region of interest, expressed in gm/ml.
[Oral contrast was administered prior to imaging.]
[In a separate acquisition, a second set of images was obtained from the vertex to the skull base; images were reconstructed and reviewed in a similar fashion.]
[A second set of images with a larger matrix frame was obtained from the vertex to the base of the neck.]
Findings: Evaluation of the brain demonstrates no abnormality in the radiotracer distribution of the cortex, deep subcortical structures, and the cerebellum.
Evaluation of the neck demonstrates normal uptake within the cervical lymph nodes. There is normal uptake within the salivary glands, visualized portions of the brain, and remaining cervical structures.
Evaluation of the thorax demonstrates no abnormal uptake within the lungs. Physiologic myocardial uptake is present. There are no hypermetabolic mediastinal lymph nodes.
Examination of the abdomen and pelvis shows normal uptake within the adrenal glands, liver, spleen, renal cortices and collecting system. There are no hypermetabolic lymph nodes.
No metabolically active areas are noted within the osseous structures.
Evaluation of the musculoskeletal structures reveals 
Impression: [Normal/Abormal] F18 FDG-PET/CT scintigraphy.
No evidence of hypermetabolic foci throughout the neck, chest, abdomen, and pelvis.